Jeffrey D. Hermes

3.6k total citations
51 papers, 2.7k citations indexed

About

Jeffrey D. Hermes is a scholar working on Molecular Biology, Oncology and Biochemistry. According to data from OpenAlex, Jeffrey D. Hermes has authored 51 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Biochemistry. Recurrent topics in Jeffrey D. Hermes's work include Peptidase Inhibition and Analysis (6 papers), Amino Acid Enzymes and Metabolism (5 papers) and Immune Cell Function and Interaction (5 papers). Jeffrey D. Hermes is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Amino Acid Enzymes and Metabolism (5 papers) and Immune Cell Function and Interaction (5 papers). Jeffrey D. Hermes collaborates with scholars based in United States, Switzerland and United Kingdom. Jeffrey D. Hermes's co-authors include W. W. Cleland, W. W. Cleland, Vincent L. Pecoraro, Marion H. O’Leary, Paul M. Weiss, Alice I. Marcy, Stephen C. Blacklow, Jeremy R. Knowles, William K. Hagmann and Richard Cummings and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Jeffrey D. Hermes

51 papers receiving 2.5k citations

Peers

Jeffrey D. Hermes
Steven R. Jordan United States
Joanne L. Parker United Kingdom
Ward W. Smith United States
Brian F.P. Edwards United States
John Spurlino United States
Joseph W. Becker United States
James G. Omichinski United States
Steven R. Jordan United States
Jeffrey D. Hermes
Citations per year, relative to Jeffrey D. Hermes Jeffrey D. Hermes (= 1×) peers Steven R. Jordan

Countries citing papers authored by Jeffrey D. Hermes

Since Specialization
Citations

This map shows the geographic impact of Jeffrey D. Hermes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey D. Hermes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey D. Hermes more than expected).

Fields of papers citing papers by Jeffrey D. Hermes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey D. Hermes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey D. Hermes. The network helps show where Jeffrey D. Hermes may publish in the future.

Co-authorship network of co-authors of Jeffrey D. Hermes

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey D. Hermes. A scholar is included among the top collaborators of Jeffrey D. Hermes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey D. Hermes. Jeffrey D. Hermes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yaping, Jeffrey D. Hermes, Jing Li, & Matthew Tudor. (2018). Endogenous Locus Reporter Assays. Methods in molecular biology. 1755. 163–177. 3 indexed citations
2.
Finley, Michael, et al.. (2016). Development of a Platform to Enable Fully Automated Cross-Titration Experiments. SLAS TECHNOLOGY. 22(2). 195–205. 4 indexed citations
3.
Meng, Juncai, Ming‐Tain Lai, Vandna Munshi, et al.. (2015). Screening of HIV-1 Protease Using a Combination of an Ultra-High-Throughput Fluorescent-Based Assay and RapidFire Mass Spectrometry. SLAS DISCOVERY. 20(5). 606–615. 18 indexed citations
4.
Adam, Gregory C., Juncai Meng, Joseph M. Rizzo, et al.. (2014). Use of High-Throughput Mass Spectrometry to Reduce False Positives in Protease uHTS Screens. SLAS DISCOVERY. 20(2). 212–222. 27 indexed citations
5.
Nguyen, Kevin, Marc Ferrer, Jeremy S. Caldwell, et al.. (2011). Parsimonious Discovery of Synergistic Drug Combinations. ACS Chemical Biology. 6(12). 1391–1398. 18 indexed citations
6.
Hunt, Julianne A., Richard T. Beresis, Mark A. Holmes, et al.. (2009). Disubstituted pyrimidines as Lck inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(18). 5440–5443. 6 indexed citations
7.
Xiong, Yusheng, Judyann Wiltsie, Andrea Woods, et al.. (2005). The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection. Bioorganic & Medicinal Chemistry Letters. 16(4). 964–968. 44 indexed citations
8.
Zhou, Gaochao, Richard Cummings, Jeffrey D. Hermes, & David E. Moller. (2001). Use of Homogeneous Time-Resolved Fluorescence Energy Transfer in the Measurement of Nuclear Receptor Activation. Methods. 25(1). 54–61. 34 indexed citations
9.
Park, Young-Whan, Richard Cummings, Lin Wu, et al.. (1999). Homogeneous Proximity Tyrosine Kinase Assays: Scintillation Proximity Assay versus Homogeneous Time-Resolved Fluorescence. Analytical Biochemistry. 269(1). 94–104. 96 indexed citations
10.
Jones, A. Brian, John J. Acton, Richard Cummings, et al.. (1999). Tetrapeptide derived inhibitors of complexation of a class II MHC: the peptide backbone is not inviolate. Bioorganic & Medicinal Chemistry Letters. 9(14). 2109–2114. 3 indexed citations
11.
Salowe, Scott P. & Jeffrey D. Hermes. (1998). Competitive and Slow-Binding Inhibition of Calcineurin by Drug · Immunophilin Complexes. Archives of Biochemistry and Biophysics. 355(2). 165–174. 9 indexed citations
12.
Sonatore, Lisa M., et al.. (1996). The Utility of FK506-Binding Protein as a Fusion Partner in Scintillation Proximity Assays: Application to SH2 Domains. Analytical Biochemistry. 240(2). 289–297. 7 indexed citations
13.
Zweerink, Hans J., Maureen C. Gammon, Ursula Utz, et al.. (1993). Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. The Journal of Immunology. 150(5). 1763–1771. 88 indexed citations
14.
Salowe, Scott P., Alice I. Marcy, Catherine K. Smith, et al.. (1992). Characterization of zinc-binding sites in human stromelysin-1: stoichiometry of the catalytic domain and identification of a cysteine ligand in the proenzyme. Biochemistry. 31(19). 4535–4540. 66 indexed citations
15.
Anderson, Karen S., Peter Cresswell, M T Gammon, et al.. (1991). Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis.. The Journal of Experimental Medicine. 174(2). 489–492. 190 indexed citations
16.
Marcy, Alice I., Richard K. Harrison, Nancy I. Hutchinson, et al.. (1991). Human fibroblast stromelysin catalytic domain: expression, purification, and characterization of a C-terminally truncated form. Biochemistry. 30(26). 6476–6483. 82 indexed citations
17.
Hermes, Jeffrey D., Stephen C. Blacklow, & Jeremy R. Knowles. (1990). Searching sequence space by definably random mutagenesis: improving the catalytic potency of an enzyme.. Proceedings of the National Academy of Sciences. 87(2). 696–700. 92 indexed citations
18.
Weiss, Paul M., Paul Cook, Jeffrey D. Hermes, & W. W. Cleland. (1987). Evidence from nitrogen-15 and solvent deuterium isotope effects on the chemical mechanism of adenosine deaminase. Biochemistry. 26(23). 7378–7384. 57 indexed citations
19.
Hermes, Jeffrey D., Stephen C. Blacklow, & J.R. Knowles. (1987). The Development of Enzyme Catalytic Efficiency: An Experimental Approach. Cold Spring Harbor Symposia on Quantitative Biology. 52(0). 597–602. 18 indexed citations
20.
Rendina, Alan R., Jeffrey D. Hermes, & W. W. Cleland. (1984). Use of multiple isotope effects to study the mechanism of 6-phosphogluconate dehydrogenase. Biochemistry. 23(25). 6257–6262. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026